Perrigo Co PLC (PRGO)

41.17 +0.79  +1.96% NYSE Apr 15, 20:00 USD
View Full Chart
Price Chart
View All PRGO News

News

View All Events

Events

Date Type Description
04/30/2020 08:30 EDT Earnings Calls Q1 2020 Earnings Call
04/30/2020 00:00 Earnings Results Q1 2020 Earnings Results
05/06/2020 11:30 IST Agm 2019 Annual General Meeting
05/28/2020 None Dividends 0.225 Normal, declared May 05, 2020 and paid June 16, 2020
08/05/2020 09:00 EDT Earnings Calls Q2 2020 Earnings Call
08/05/2020 00:00 Earnings Results Q2 2020 Earnings Results
08/27/2020 None Dividends 0.225 Normal, declared July 29, 2020 and paid September 15, 2020
11/04/2020 00:00 Earnings Results Q3 2020 Earnings Results
11/04/2020 16:30 EST Earnings Calls Q3 2020 Earnings Call
11/25/2020 None Dividends 0.225 Normal, declared October 22, 2020 and paid December 15, 2020
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Perrigo is the leading provider of over-the-counter generic drugs with over 100 global locations. The company was formed in 1887 as a packager of home remedies and has grown with the migration of prescriptions switching to OTC and later with strategic acquisitions. The company has a portfolio of more than 3,000 product formulations and 14,000 stock-keeping units. Most of its manufacturing and customer base reside in North America. With the most recent management change, the company announced a narrower focus on consumer wellness in conjunction with the divestiture of animal health, acquisition of Ranir Global Holdings, and plans to sell or spin off the prescription business.
  • URL: https://www.perrigo.com
  • Investor Relations URL: http://perrigo.investorroom.com/
  • HQ State/Province: N/A
  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Equity Style: Small Cap/Value
  • Next Earnings Release: Apr. 30, 2021
  • Last Earnings Release: Mar. 01, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: Mar. 11, 2021

Top Fund Holders

Symbol Name Weighting
XPH SPDR® S&P Pharmaceuticals ETF 4.29%
SLVCX Saratoga Large Capitalization Value C 3.40%
PILL Direxion Daily Phrmctcl&MdclBl3XShrsETF 3.10%
PJP Invesco Dynamic Pharmaceuticals ETF 3.00%
SSHVX Sound Shore Institutional 2.94%
CSINX Centerstone International C 2.50%
TMPRX Touchstone Mid Cap R6 2.37%
CBMCX Wells Fargo C&B Mid Cap Value C 2.07%
IHE iShares US Pharmaceuticals ETF 2.03%
MFCCX Meridian Contrarian C 2.01%
PPH VanEck Vectors Pharmaceutical ETF 1.44%
GRX Gabelli Health & Wellness 1.39%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.